Oral Mucosal Lesions Among Smokers in an Egyptian Population.
NCT ID: NCT03299595
Last Updated: 2021-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
824 participants
OBSERVATIONAL
2017-11-01
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oral Mucosal Lesions Among Smokers in an Egyptian Population Study.
NCT03299634
Oral Manifestation of COVID 19 Patient: A Cross Sectional Study on Egyptian Population
NCT04391881
Prevalence of Oral Mucosal Alterations in Mucocutaneous Ocular Disorders
NCT03679988
Prevalence of Oral Mucosal Alterations In a Sample of Egyptian Patients With Cardiovascular Diseases: A Hospital- Based Cross-Sectional Study
NCT04511403
Prevalence of Oral Lesions in COVID-19 Patients
NCT04917549
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
printed questionnaire
For each eligible participant, a full history will be obtained according to a questionnaire followed by thorough clinical examination.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age: all age groups.
* Smokers.
* Individuals who agreed to sign the informed consent.
Exclusion Criteria
* Individuals on medications.
* Non-Egyptians.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alaa Shousha
resident
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Dentistry
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEBC-CU-2017-08-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.